Position in BCRX
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$67,753,490
+$6,895,672 QoQ
Shares Held
6,775,349
+6.0% QoQ
Ownership
2.65%
of shares outstanding
% of Portfolio
0.06%
of 13F equity value
Holder Rank
#11
of 316 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 99%
Shared 0%
None 1%
Common Shares in BCRX Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Jun 30, 2026TWO SIGMA INVESTMENTS, LP holds $775,744,366 across 48 Drug Manufacturers - Specialty & Generic names. BCRX ranks #2 (8.7% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | NBIX |
Neurocrine Biosciences Inc
|
2,076,260 | $349,932,860 | |
| 2 | BCRX |
Biocryst Pharmaceuticals Inc
This page
|
6,775,349 | $67,753,490 | |
| 3 | SUPN |
Supernus Pharmaceuticals, Inc.
|
1,184,378 | $55,085,420 | |
| 4 | ALKS |
Alkermes plc.
|
1,038,311 | $54,407,496 | |
| 5 | KNSA |
Kiniksa Pharmaceuticals International, plc
|
561,480 | $35,906,646 | |
| 6 | ZTS |
Zoetis Inc.
|
386,428 | $27,768,716 | |
| 7 | LQDA |
Liquidia Corp
|
266,829 | $21,274,276 | |
| 8 | IRWD |
Ironwood Pharmaceuticals Inc
|
4,556,089 | $19,181,134 |
All Filings in BCRX
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $67,753,490 | 6,775,349 | Shares | Sole | 2026-08-14 | |
| 2026-03-31 | $60,857,818 | 6,392,628 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $35,219,472 | 4,515,317 | Shares | Sole | 2026-02-17 | |
| 2025-09-30 | $33,544,984 | 4,419,629 | Shares | Sole | 2025-11-14 | |
| 2025-06-30 | $38,422,478 | 4,288,223 | Shares | Sole | 2025-08-14 | |
| 2025-03-31 | $15,341,512 | 2,045,535 | Shares | Sole | 2025-05-15 | |
| 2024-12-31 | $13,342,089 | 1,774,214 | Shares | Sole | 2025-02-14 | |
| 2024-09-30 | $13,382,140 | 1,760,808 | Shares | Sole | 2024-11-14 | |
| 2024-06-30 | $10,347,736 | 1,674,391 | Shares | Sole | 2024-08-14 | |
| 2024-03-31 | $7,999,176 | 1,574,641 | Shares | Sole | 2024-05-15 | |
| 2023-12-31 | $14,086,802 | 2,351,720 | Shares | Sole | 2024-02-14 | |
| 2023-09-30 | $12,433,506 | 1,756,145 | Shares | Sole | 2023-11-14 | |
| 2023-06-30 | $9,373,675 | 1,331,488 | Shares | Sole | 2023-08-14 | |
| 2023-03-31 | $11,178,252 | 1,340,318 | Shares | Sole | 2023-05-15 | |
| 2022-12-31 | $5,899,652 | 513,907 | Shares | Sole | 2023-02-14 | |
| 2022-09-30 | $12,992,603 | 1,031,159 | Shares | Sole | 2022-11-14 | |
| 2022-06-30 | $2,566,083 | 242,541 | Shares | Sole | 2022-08-15 | |
| 2022-03-31 | $3,237,756 | 199,124 | Shares | Sole | 2022-05-16 | |
| 2021-12-31 | $16,941,167 | 1,223,189 | Shares | Sole | 2022-02-14 | |
| 2021-09-30 | $32,586,058 | 2,267,645 | Shares | Sole | 2021-11-15 | |
| 2021-06-30 | $29,256,167 | 1,850,485 | Shares | Sole | 2021-08-16 | |
| 2021-03-31 | $593,612 | 58,369 | Shares | Sole | 2021-05-17 | |
| 2020-12-31 | $7,996,949 | 1,073,416 | Shares | Sole | 2021-02-16 | |
| 2020-09-30 | $6,761,110 | 1,965,439 | Shares | Sole | 2020-11-16 | |
| 2020-06-30 | $13,629,693 | 2,863,381 | Shares | Sole | 2020-08-14 | |
| 2020-03-31 | $2,263,042 | 1,131,521 | Shares | Sole | 2020-05-15 | |
| No filing history on record for this holder in this stock. | ||||||